September, 2025
September 2025
M T W T F S S
1234567
891011121314
15161718192021
22232425262728
2930  
Nico Gagelmann: Ide-cel versus cilta-cel for relapsed or refractory multiple myeloma
Jan 19, 2025, 22:11

Nico Gagelmann: Ide-cel versus cilta-cel for relapsed or refractory multiple myeloma

Nico Gagelmann, Chair of the CAR-T for plasma cell disorder committee at The EBMT, shared a post on X about a recent paper by him and colleagues published in HemaSphere:

“Finally published!

Ide-cel versus cilta-cel for relapsed or refractory multiple myeloma.”

“Idecabtagene vicleucel or ciltacabtagene autoleucel for relapsed or refractory multiple myeloma: An international multicenter study”

Authors: Maximilian Merz, Anca-Maria Albici, Bastian von Tresckow, Thomas Pabst, Nico Gagelmann et al.

Nico Gagelmann: Ide-cel versus cilta-cel for relapsed or refractory multiple myeloma

More posts featuring Nico Gagelmann.